Investing.com - EDAP reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
EDAP announced earnings per share of €-0.03 on revenue of €9.45M. Analysts polled by Investing.com anticipated EPS of €-0.02 on revenue of €7.83M.
EDAP shares are down 7% from the beginning of the year and are trading at €4.12 , down-from-52-week-high.They are under-performing the Nasdaq which is up 31.97% from the start of the year.
EDAP follows other major Healthcare sector earnings this month
EDAP's report follows an earnings beat by Merck&Co on Tuesday, October 27, 2020, who reported EPS of €1.74 on revenue of €12.55B, compared to forecasts EPS of €1.44 on revenue of €12.21B.
Pfizer had beat expectations on Tuesday, October 27, 2020 with third quarter EPS of €0.72 on revenue of €12.13B, compared to forecast for EPS of €0.71 on revenue of €12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar